Emphasizing Sustainability in Contract Manufacturing
Ajinomoto Bio-Pharma Services outlines its commitment to protecting the environment.
APIs
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
JSR Life Sciences Expands European Footprint
Will co-locate primary European operations for affiliate companies KBI Biopharma and Selexis SA in Geneva’s ZIPLO campus.10.20.20
-
APIs
-
APIs
Understanding the Importance of Crystallization Processes
Crystallization is a crucial aspect of a molecule’s development and can be used to avoid unnecessary cost, risk and development delays.Dr. Craig Callahan, Project Scientist, Cambrex Edinburgh 10.14.20
-
APIs | Breaking News | Facilities | Industry News
Sterling Pharma Solutions Expands US Operations
Acquires Alcami’s Germantown, WI API facility.Contract Pharma Staff 10.02.20
-
APIs | Breaking News | Industry News
NCK A/S Receives CoA for Berubicin API
CNS has a contract with NCK A/S for the large-scale production of Berubicin, its lead drug candidate for the treatment of glioma brain tumors.Contract Pharma Staff 10.01.20
-
APIs | Breaking News | cGMP Manufacture | Industry News
BIAL, Recipharm Expand Long-Term API Supply Pact
Expanded agreement follows approval and launch of Opicapone in Japan to treat Parkinson’s.Contract Pharma Staff 10.01.20
-
APIs | Formulation Development
Premature Release from Wurster Fluid Bed Enteric Coatings
The Wurster (bottom spray) fluid bed coating process provides an optimal means to apply enteric coatings on API or API containing particles.
-
APIs | Drug Development | Risk Management
Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach
Small-molecule drug development has become more complex and challenging, leading to greater reliance on CDMOs.Sarah Bethune, Cambrex 09.09.20
-
APIs
Production Scale Up to Meet COVID-19 Demand
Rigorous process design and a robust supply chain are essential to support rapid scale up of API production in response to COVID-19.Ilan Avni, Wavelength Pharmaceuticals 09.09.20
-
APIs | Breaking News | Chemistry | Collaborations & Alliances | Industry News | Process Development
Faes Farma Chooses Syrris Asia to Develop Continuous Flow Processes
Acquired a Syrris Asia system in early 2018 with the aim of developing a new synthetic pathway for an existing API.Contract Pharma Staff 09.08.20
-
APIs | Formulation Development
Expanding Solutions for Challenging APIs Through Coacervation
Download Adare Pharmaceuticals whitepaper to learn how the coacervation method can help solve your formulation challenges.
-
APIs | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Excipients | Formulation Development | Industry News
Piramal to Deliver Integrated Services to Epirium
Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.Contract Pharma Staff 08.27.20
-
APIs | Breaking News | cGMP Manufacture | Industry News
Aji Bio-Pharma Expands Small Molecule Mfg. Capabilities
To add a new 8,500 square meter production facility in Visakhapatnam, India.Contract Pharma Staff 08.13.20
-
APIs | Clinical Trial Materials | Process Validation | QA/QC | Regulatory Affairs
-
APIs | Breaking News | Industry News
LGM Acquires Pharmaceutical Development & Manufacturing Unit of Nexgen
Gains 150 employees and more than 100,000 square feet of fully equipped facilities.Contract Pharma Staff 07.27.20
-
APIs | Breaking News | Industry News
ChemWerth Files its 500th Drug Master File with FDA
API supplier supports both large and small finished dosage companies worldwide.Contract Pharma Staff 07.23.20
-
APIs | Breaking News | Facilities | Industry News
CordenPharma Increases U.S. Peptide Manufacturing Capacity
Expansion aims to accommodate a large spike in demand for peptide API’s.Contract Pharma Staff 07.08.20
-
APIs | Aseptic Processing
Sterile Manufacturing Technology Trends
Eliminating the risk of contamination in biologics manufacturing with SBV technology.Online Exclusives Christian Dunne, Head of Sterile Solutions, ChargePoint Technology 07.02.20
-
APIs
Extrusion-Spheronization, Engineered for Today’s Controlled Release Forms
Synchronizing and controlling API delivery, E-S offers pharmaceutical companies a robust technique to manufacture today’s most complex therapeutics.
-
APIs | Breaking News | cGMP Manufacture | Industry News
Cambrex Investing $3.6M at Sweden Facility
To increase flexible drug substance manufacturing capacity by 25%.Contract Pharma Staff 07.01.20
